Related references
Note: Only part of the references are listed.Cytokeratin-19 and Mammaglobin Gene Expression in Circulating Tumor Cells from Metastatic Breast Cancer Patients Enrolled in North Central Cancer Treatment Group Trials, N0234/336/436/437
Monica M. Reinholz et al.
CLINICAL CANCER RESEARCH (2011)
Comparison of estrogen and progesterone receptor status of circulating tumor cells and the primary tumor in metastatic breast cancer patients
Bahriye Aktas et al.
GYNECOLOGIC ONCOLOGY (2011)
The prognostic significance of tumour cell detection in the peripheral blood versus the bone marrow in 733 early-stage breast cancer patients
Timothy J. Molloy et al.
BREAST CANCER RESEARCH (2011)
Circulating tumor cells as prognostic and predictive markers in metastatic breast cancer patients receiving first-line systemic treatment
Mario Giuliano et al.
BREAST CANCER RESEARCH (2011)
Single circulating tumor cell detection and overall survival in nonmetastatic breast cancer
F. -C. Bidard et al.
ANNALS OF ONCOLOGY (2010)
Detection and HER2 Expression of Circulating Tumor Cells: Prospective Monitoring in Breast Cancer Patients Treated in the Neoadjuvant GeparQuattro Trial
Sabine Riethdorf et al.
CLINICAL CANCER RESEARCH (2010)
Multi-center study evaluating circulating tumor cells as a surrogate for response to treatment and overall survival in metastatic breast cancer
Seigo Nakamura et al.
BREAST CANCER (2010)
Molecular profiling and predictive value of circulating tumor cells in patients with metastatic breast cancer: an option for monitoring response to breast cancer related therapies
Mitra Tewes et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Detection of cytokeratin-19 mRNA-positive cells in the peripheral blood and bone marrow of patients with operable breast cancer
A. Daskalaki et al.
BRITISH JOURNAL OF CANCER (2009)
Circulating Tumor Cells: A Useful Predictor of Treatment Efficacy in Metastatic Breast Cancer
Minetta C. Liu et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Detection and characterization of circulating tumor cells in blood of primary breast cancer patients by RT-PCR and comparison to status of bone marrow disseminated cells
Tanja Fehm et al.
BREAST CANCER RESEARCH (2009)
Variation of circulating tumor cell levels during treatment of metastatic breast cancer:: prognostic and therapeutic implications
F. Nole et al.
ANNALS OF ONCOLOGY (2008)
Circulating Tumor Cells in Metastatic Breast Cancer From Prognostic Stratification to Modification of the Staging System?
Shaheenah Dawood et al.
CANCER (2008)
Circulating Tumor Cell Detection Predicts Early Metastatic Relapse After Neoadjuvant Chemotherapy in Large Operable and Locally Advanced Breast Cancer in a Phase II Randomized Trial
Jean-Yves Pierga et al.
CLINICAL CANCER RESEARCH (2008)
Prognosis of women with stage IV breast cancer depends on detection of circulating tumor cells rather than disseminated tumor cells
F. -C. Bidard et al.
ANNALS OF ONCOLOGY (2008)
Adoptive transfer of autologous, HER2-specific, cytotoxic T lymphocytes for the treatment of HER2-overexpressing breast cancer
Helga Bernhard et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
ERalpha-status of disseminated tumour cells in bone marrow of primary breast cancer patients
Tanja Fehm et al.
BREAST CANCER RESEARCH (2008)
Primary systemic therapy does not eradicate disseminated tumor cells in breast cancer patients
Sven Becker et al.
BREAST CANCER RESEARCH AND TREATMENT (2007)
Molecular detection and prognostic value of circulating cytokeratin-19 messenger RNA-positive and HER2 messenger RNA-positive cells in the peripheral blood of women with early-stage breast cancer
Michail Ignatiadis et al.
CLINICAL BREAST CANCER (2007)
Circulating tumor cells versus imaging - Predicting overall survival in metastatic breast cancer
G. Thomas Budd et al.
CLINICAL CANCER RESEARCH (2006)
Detection of Mammaglobin A-mRNA-positive circulating tumor cells in peripheral blood of patients with operable breast cancer with nested RT-PCR
Maria Ntoulia et al.
CLINICAL BIOCHEMISTRY (2006)
Predictive and prognostic value of peripheral blood cytokeratin-19 mRNA-positive cells detected by real-time polymerase chain reaction in node-negative breast cancer patients
Nikos Xenidis et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Circulating tumor cells at each follow-up time point during therapy of metastatic breast cancer patients predict progression-free and overall survival
Daniel F. Hayes et al.
CLINICAL CANCER RESEARCH (2006)
Comparison of HER2 status between primary tumor and disseminated tumor cells in primary breast cancer patients
Erich F. Solomayer et al.
BREAST CANCER RESEARCH AND TREATMENT (2006)
Quantitative real-time RT-PCR of disseminated tumor cells in combination with immunomagnetic cell enrichment
Silke Lankiewicz et al.
MOLECULAR BIOTECHNOLOGY (2006)
Presence of apoptotic and nonapoptotic disseminated tumor cells reflects the response to neoadjuvant systemic therapy in breast cancer
Tanja Fehm et al.
BREAST CANCER RESEARCH (2006)
A pooled analysis of bone marrow micrometastasis in breast cancer
S Braun et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Circulating tumor cells in breast cancer:: Correlation to bone marrow micrometastases, heterogeneous response to systemic therapy and low proliferative activity
V Müller et al.
CLINICAL CANCER RESEARCH (2005)
Methods for isolating circulating epithelial cells and criteria for their classification as carcinoma cells
T Fehm et al.
CYTOTHERAPY (2005)
The persistence of isolated tumor cells in bone marrow from patients with breast carcinoma predicts an increased risk for recurrence
W Janni et al.
CANCER (2005)
Circulating tumor cells: A novel prognostic factor for newly diagnosed metastatic breast cancer
M Cristofanilli et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
American Cancer Society guidelines for the early detection of cancer, 2005
RA Smith et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2005)
Clinical significance of immunocytochemical detection of tumor cells using digital microscopy in peripheral blood and bone marrow of breast cancer patients
JY Pierga et al.
CLINICAL CANCER RESEARCH (2004)
Circulating tumor cells, disease progression, and survival in metastatic breast cancer
M Cristofanilli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Circulating tumor cells in patients with breast cancer dormancy
SD Meng et al.
CLINICAL CANCER RESEARCH (2004)
Trastuzumab administration can effectively target chemotherapy-resistant cytokeratin-19 messenger RNA-positive tumor cells in the peripheral blood and bone marrow of patients with breast cancer
V Bozionellou et al.
CLINICAL CANCER RESEARCH (2004)
HER-2 gene amplification can be acquired as breast cancer progresses
SD Meng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Detection of micrometastatic disease and monitoring of perioperative tumor cell dissemination in primary operable breast cancer patients using real-time quantitative reverse transcription-PCR
MS Ismail et al.
CLINICAL CANCER RESEARCH (2004)
Prognostic significance of occult tumor cells in the apheresis products of patients with advanced breast cancer receiving high-dose chemotherapy and autologous hematopoietic progenitor cell support
Y Nieto et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2004)
Genetic heterogeneity of single disseminated tumour cells in minimal residual cancer
CA Klein et al.
LANCET (2002)
Molecular detection of cytokeratin-19-positive cells in the peripheral blood of patients with operable breast cancer: Evaluation of their prognostic significance
A Stathopoulou et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Share Paper
